Ally Bridge Group (Ny) LLC Edgewise Therapeutics, Inc. Transaction History
Ally Bridge Group (Ny) LLC
- $76.1 Million
- Q1 2025
A detailed history of Ally Bridge Group (Ny) LLC transactions in Edgewise Therapeutics, Inc. stock. As of the latest transaction made, Ally Bridge Group (Ny) LLC holds 102,650 shares of EWTX stock, worth $1.3 Million. This represents 2.97% of its overall portfolio holdings.
Number of Shares
102,650
Previous 83,176
23.41%
Holding current value
$1.3 Million
Previous $2.22 Million
1.71%
% of portfolio
2.97%
Previous 2.52%
Shares
3 transactions
Others Institutions Holding EWTX
# of Institutions
220Shares Held
105MCall Options Held
2.57MPut Options Held
1.58M-
Orbimed Advisors LLC San Diego, CA15MShares$190 Million10.3% of portfolio
-
Ra Capital Management, L.P. Boston, MA8.91MShares$113 Million4.07% of portfolio
-
Perceptive Advisors LLC New York, NY6.55MShares$83 Million6.03% of portfolio
-
Baker Bros. Advisors LP New York, NY6.16MShares$78.1 Million1.61% of portfolio
-
Black Rock Inc. New York, NY6.02MShares$76.3 Million0.0% of portfolio
About Edgewise Therapeutics, Inc.
- Ticker EWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 63,171,700
- Market Cap $801M
- Description
- Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy which has c...